Development and Regeneration of the Endocrine Pancreas

在胰岛发育和再生领域，概述了一项研究计划，其中包括基因/蛋白质发现计划，转录调控和细胞信号研究，并解决了工程β细胞通过体外扩增和分化移植到人类受试者的实际目标：项目1(Hutton/Duncan)：发育中的内分泌胰腺的蛋白质组和基因组分析。项目2(Sussell/Lee)：分析Neurd和Nkx2.2在成人胰岛维持和再生中的功能。项目3(Levine/Stuart)：人类β细胞系。项目4(Jensen)：成人胰腺内分泌新生的诱导。支持两个核心，一个是行政信息学的核心，另一个是为贝塔细胞分离和功能分析领域的所有项目提供服务的核心。该项目直接涉及Beta细胞生物学联盟概述的6个科学调查目标领域中的2个(Beta细胞生物学联盟概述的科学调查的β细胞开发/细胞培养(人胰腺β细胞的β细胞开发/细胞培养模型))。此外，他们将使用与RFA中的另外两个目标(识别干细胞/祖细胞/评估用于移植的胰岛)相关的方法来生成数据。项目1中使用的蛋白质组和基因组学方法将产生丰富的数据，这些数据将放在核心A信息学部分支持的网站上，供联合会成员和整个糖尿病研究界进行挖掘。主要研究人员和联合研究人员包括高级和初级研究人员，他们来自广泛的学科(生物化学/遗传学/分子生物学/细胞生物学/发育生物学)，他们的共同目标是生产基于细胞的1型糖尿病治疗方法。该项目将主要设在丹佛的芭芭拉·戴维斯儿童糖尿病中心，该中心将在免疫学、人类遗传学和移植生物学领域与临床医生、临床研究人员和基础科学家进行进一步的互动。BDC是美国国立卫生研究院糖尿病和内分泌研究中心，将通过动物资源、细胞计量学、分子资源和临床核心为该计划提供支持。

A Program of research is outlined in the area of pancreatic islet development and regeneration that incorporates a gene/protein discovery program, studies in transcription regulation and cell signaling and addresses the practical goal of engineering beta-cell for transplantation into human subjects through expansion and differentiation ex vivo: PROJECT 1 (Hutton/Duncan): Proteomic and Genomic Analysis of the Developing Endocrine Pancreas. PROJECT 2 (Sussell/Lee): Analysis of the Functions of NeuroD and Nkx2.2 in the Maintenance and Regeneration of the Adult Islet. PROJECT 3 (Levine/Stuart): Human beta-Cell Lines. PROJECT 4 (Jensen): Induction of endocrine neogenesis of endocrine neogenesis from adult pancreas. Two Cores are supported one in are of Administration Informatics), a second providing services to all the projects in the area beta-cell isolation and function analysis. The project directly addresses 2 of the 6 target areas of scientific investigation outlined in the Beta Cell Biology Consortium (beta cell development/cell culture of scientific investigation outlined in the Beta Cell Biology Consortium (beta cell development/cell culture model of the human pancreatic-beta cell). In addition they will generate data using methodologies of relevance to two further aims in the RFA (identification of stem/progenitor cells/evaluation of pancreatic islets for transplantation). The proteomic and genomic approach used in Project 1 will produce a wealth of data that will be placed on a web site supported by the informatics component of Core A that will be accessible for mining by Consortium members and the diabetes research community at large. The principal investigators and co-investigators include both senior and more junior investigators who come from a wide range of disciplines (biochemistry/genetics/molecular biology/cell biology/developmental biology) linked by the common goal of producing cell-based therapy for type 1 diabetes. The Program will be located principally at the Barbara Davis Center for Childhood Diabetes in Denver which will provide further interactions with clinicians, clinical researchers and basic scientists in the area of immunology, human genetics and transplant biology. The BDC is a NIH Diabetes and Endocrine Research Center that will provide support for the Program through Animal Resources, Cytometry, Molecular Resources and a Clinical Core.